Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase dahl S hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 310, Issue 3, 2016, Pages R262-R267

  Foss, Jason D ^a   Fink, Gregory D ^b   Osborn, John W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Afferent renal nerves; Dahl salt sensitive rat; Efferent renal nerves; Renal denervation

Indexed keywords

SODIUM CHLORIDE; SALT INTAKE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DRUG EFFECT; EFFERENT NERVE; EXPERIMENTAL HYPERTENSION; FEEDING; KIDNEY DENERVATION; KIDNEY NERVE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; ANIMAL; ARTERIAL PRESSURE; AUTONOMIC DENERVATION; COMPARATIVE STUDY; DAHL RAT; DISEASE MODEL; HYPERTENSION; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; PROCEDURES; SALT INTAKE; TIME FACTOR;

AFFERENT PATHWAYS; ANIMALS; ARTERIAL PRESSURE; AUTONOMIC DENERVATION; DISEASE MODELS, ANIMAL; EFFERENT PATHWAYS; HYPERTENSION; KIDNEY; MALE; RATS, INBRED DAHL; SODIUM CHLORIDE, DIETARY; TIME FACTORS;

EID: 84956876181     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00408.2015     Document Type: Article

References (30)

1. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 63: 1791–1800, 2003.
2. Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J, Tank J. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult- to-control hypertensive patients: prospective case series. Hypertension 60: 1485–1490, 2012.
3. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25: 878–882, 1995.
4. Davis MI, Filion KB, Zhang D, Eisenberg MJ, Afilalo J, Schiffrin EL, Joyal D. Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol 62: 231–241, 2013.
5. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 77: 75–197, 1997.
6. Ezzahti M, Moelker A, Friesema EC, van der Linde NA, Krestin GP, van den Meiracker AH. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension. J Hypertens 32: 135–141, 2014.
7. Foss JD, Fink GD, Osborn JW. Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension 61: 806–811, 2013.
8. Foss JD, Wainford RD, Engeland WC, Fink GD, Osborn JW. A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin. Am J Physiol Regul Integr Comp Physiol 308: R112–R122, 2015.
9. Gu JW, Tian N, Shparago M, Tan W, Bailey AP, Manning RD Jr. Renal NF- B activation and TNF- upregulation correlate with saltsensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 291: R1817–R1824, 2006.
10. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 61: 457–464, 2013.
11. Jacob F, Ariza P, Osborn JW. Renal denervation chronically lowers arterial pressure independent of dietary sodium intake in normal rats. Am J Physiol Heart Circ Physiol 284: H2302–H2310, 2003.
12. Jacob F, Clark LA, Guzman PA, Osborn JW. Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach. Am J Physiol Heart Circ Physiol 289: H1519–H1529, 2005.
13. Jacob F, LaBine BG, Ariza P, Katz SA, Osborn JW. Renal denervation causes chronic hypotension in rats: Role of ß1-adrenoceptor activity. Clin Exp Pharmacol Physiol 32: 255–262, 2005.
14. Kopp UC, Cicha MZ, Smith LA. Dietary sodium loading increases arterial pressure in afferent renal-denervated rats. Hypertension 42: 968–973, 2003.
15. Li M, Galligan J, Wang D, Fink G. The effects of celiac ganglionectomy on sympathetic innervation to the splanchnic organs in the rat. Auton Neurosci 154: 66–73, 2010.
16. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747–1757, 2006.
17. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Boehm M. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 60: 419–424, 2012.
18. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Bohm M. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 128: 132–140, 2013.
19. Miller RJ, Jung H, Bhangoo SK, White FA. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 417–449, 2009.
20. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension 49: 69–75, 2007.
21. Poss J, Ewen S, Schmieder RE, Muhler S, Vonend O, Ott C, Linz D, Geisel J, Rump LC, Schlaich M, Bohm M, Mahfoud F. Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension. Clin Res Cardiol 104: 672–678, 2015.
22. Seifi B, Kadkhodaee M, Xu J, Soleimani M. Pro-inflammatory cytokines of rat vasculature in DOCA-salt treatment. Mol Biol Rep 37: 2111–2115, 2010.
23. Steinberg JS, Pokushalov E, Mittal S. Renal denervation for arrhythmias: hope or hype? Curr Cardiol Rep 15: 392, 2013.
24. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57: 911–917, 2011.
25. Veitenheimer B, Osborn JW. Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress. Am J Physiol Regul Integr Comp Physiol 300: R460–R469, 2011.
26. Wang DH, Li J, Qiu J. Salt-sensitive hypertension induced by sensory denervation: introduction of a new model. Hypertension 32: 649–653, 1998.
27. Wang L, Lu CZ, Zhang X, Luo D, Zhao B, Yu X, Xia DS, Chen X, Zhao XD. [The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi 41: 3–7, 2013.
28. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, Michalowska I, Kabat M, Warchol E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58: 559–565, 2011.
29. Wyss JM, Aboukarsh N, Oparil S. Sensory denervation of the kidney attenuates renovascular hypertension in the rat. Am J Physiol Heart Circ Physiol 250: H82–H86, 1986.
30. Zicha J, Dobesova Z, Vokurkova M, Rauchova H, Hojna S, Kadlecova M, Behuliak M, Vaneckova I, Kunes J. Age-dependent salt hypertension in Dahl rats: fifty years of research. Physiol Res 61 Suppl 1: S35–S87, 2012.